Indications and Usage

Ixazomib is FDA approved in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Side effects needing medical attention

Diarrhea, constipation, thrombocytopenia, peripheral neuropathy, nausea, peripheral edema, skin reactions, liver problems, vomiting, back pain.

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.